Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
viral vector
2:37
The benefits of PiggyBac transposon-mediated CAR-T cell technology
Shigeki Yagyu
• 8 Apr 2022
4:51
Challenges in manufacturing viral vectors for the clinic
Nathalie Clement
• 27 Jan 2022
1:11
Improving cell therapy manufacturing capabilities
Lavakumar Karyampudi
• 27 Jan 2022
2:59
The past, present and future of AAV vectors
Nathalie Clement
• 27 Jan 2022
3:34
Innovations in viral vector development
Nathalie Clement
• 27 Jan 2022
1:51
Optimizing AAV vectors with AI
Christopher Reardon
• 27 Jan 2022
0:55
Clinical challenges in developing AAV-based gene therapies
Christopher Reardon
• 27 Jan 2022
4:31
Medical Grade Molecular Rebar: a unique nanoparticle delivery vehicle
Kurt Swogger
• 26 Jan 2022
1:45
The current landscape of viral vector-based gene therapy
Manuel Carrondo
• 6 Oct 2021
3:00
Driving the development of gene therapies for more common conditions
Paul Gissen
• 6 Oct 2021
1:17
The importance of analytical tools in cell and gene therapy manufacturing
Manuel Carrondo
• 6 Oct 2021
3:36
The gene therapy landscape for osteoarthritis
Christopher Evans
• 19 May 2021